Vietnam's Dairy Pride: Vinamilk Makes Headlines at Growth Asia Summit with 6-HMO Breakthrough

SINGAPORE, July 17, 2025 /PRNewswire/ -- At the Growth Asia Summit 2025, which took place from July 15–17 in Singapore, Vinamilk was honored to be the only Vietnamese company invited as a keynote speaker. The Growth Asia Summit is the largest forum for growth opportunities in the food, beverage, and nutrition industries in Asia. The brand made a remarkable impression with its innovative 6-HMO infant formula, setting a new standard in pediatric nutrition and paving the way for the dairy industry in Asia.

Vinamilk's presence at the Summit is symbolic; it reflects the nation's transformation from a country once struggling with post-war milk shortages into a rising nutrition powerhouse with Vinamilk at its forefront. The company currently ranks sixth globally for dairy brand value and was recognized as the most valuable food and beverage brand in Southeast Asia in Brand Finance's Food and Drink 2023 ranking. Additionally, it is the only Vietnamese dairy company featured in the Fortune Southeast Asia 500 ranking (2024), underscoring its strong market presence in the region.

In Vietnam, around 55% of infants are not exclusively breastfed during their first six months^[1]. This means many babies may miss out on the full range of benefits found in breast milk, especially human milk oligosaccharides (HMOs), which support gut and immune development. To address this gap, Vinamilk pioneered Vietnam's first formula containing six HMOs^[2]–nutrients naturally found in breast milk—to enhance both digestive and immune health. This solution is particularly impactful in a country where nearly 60% of working mothers struggle to balance both work and family commitments.

This challenge is not unique to Vietnam. Across Asia, exclusive breastfeeding rates remain modest, reaching only 52.9% in the Asia-Pacific and 48.3% in Southeast Asia^[3] primarily due to lifestyle shifts, work demands, and social pressure. This is why nutrition solutions that closely mimic breast milk, such as Vinamilk's 6-HMO innovation, received extensive attention from the Summit's expert community.

"I commend Vinamilk's breakthrough not only for advancing nutritional science with Vietnam's first 6-HMO formula, but also for its empathetic, consumer-centric approach. This is a valuable contribution to the Summit's mission of seeking comprehensive health solutions—not just in terms of nutrition, but also in creating positive social impact, especially for women and children," said Gary Scattergood, Editor-in-Chief of FoodNavigator Asia and NutraIngredients Asia, the Summit's organizing entities.

Once a market dominated by imported dairy products, Vietnam is now home to Vinamilk, the first local brand not only to catch up, but to lead regional innovation in pediatric nutrition. While the market had plateaued at 5-HMO formulas since 2021, Vinamilk chose not to compromise and instead accelerated its R&D efforts to break this ceiling.

In 2023, Vinamilk entered strategic partnerships with six leading global nutrition companies (DSM – Switzerland, Novonesis, formerly Chr. Hansen – Denmark, Beneo – Germany, Gnosis – Italy, AAK – Sweden, and Kanematsu – Japan) to enhance scientific capability and innovation in infant formula development. The launch of the Optimum line, powered by a 6-HMO formula that accounts for approximately 58% of the total HMO composition found in natural breast milk^[4], exemplifies the successful integration of research and international collaboration.

The 6-HMO innovation brings significant benefits for infant digestion and immunity. It mimics critical oligosaccharides in breast milk, fosters the development of beneficial gut bacteria in infants and protects against pathogens. The formulation also includes both difucosyllactose (DFL) and 3-fucosyllactose (3-FL), two HMOs that are rarely found together in other commercial infant formulas.

Nguyen Quang Tri, Chief Marketing Officer of Vinamilk, stated, "Our 6-HMO breakthrough not only raises nutritional standards, but also helps support parents navigating breastfeeding challenges. At Vinamilk, we believe that when parents are happy, a child's development is more complete. We believe this message doesn't just apply to Vietnam – it resonates with millions of parents across Asia."

Vinamilk's contribution to the Growth Asia Summit 2025 signals a new chapter in Vietnam's innovation journey. From a country that once had no dairy industry and lagged in nutrition science, Vietnam, through Vinamilk, is stepping into the global spotlight, confidently shaping new standards in pediatric care: proactive, empathetic, and pioneering.

For more information, please visit: https://www.vinamilk.com.vn/en.

[1] UNICEF, 2021 [2] As of March 25, 2025, all Optimum Gold and Optimum Colos products by Vinamilk are the first infant formula and pediatric nutritional milk products in Vietnam to include 6 HMOs inspired by components found in breast milk. (CI Research market report) [3] Asia and The Pacific Regional Overview of Food Security and Nutrition 2023, Chapter 3, Section 3.2 [4] The 6-HMO formula in Optimum accounts for 58% of total HMOs found in human breast milk.

[1] UNICEF, 2021

[2] As of March 25, 2025, all Optimum Gold and Optimum Colos products by Vinamilk are the first infant formula and pediatric nutritional milk products in Vietnam to include 6 HMOs inspired by components found in breast milk. (CI Research market report)

[3] Asia and The Pacific Regional Overview of Food Security and Nutrition 2023, Chapter 3, Section 3.2

[4] The 6-HMO formula in Optimum accounts for 58% of total HMOs found in human breast milk.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Vietnam's Dairy Pride: Vinamilk Makes Headlines at Growth Asia Summit with 6-HMO Breakthrough

Vietnam's Dairy Pride: Vinamilk Makes Headlines at Growth Asia Summit with 6-HMO Breakthrough

Vietnam's Dairy Pride: Vinamilk Makes Headlines at Growth Asia Summit with 6-HMO Breakthrough

Vietnam's Dairy Pride: Vinamilk Makes Headlines at Growth Asia Summit with 6-HMO Breakthrough

SHANGHAI, April 5, 2026 /PRNewswire/ -- The 93rd China International Medical Equipment Fair (CMEF) will be held from April 9 to 12 at the National Exhibition and Convention Center (NECC) in Shanghai. As the largest global medical device industry chain exhibition, this year's event under the theme of "Innovation Fusion, Boundless Evolution," will focus on cutting-edge technologies and international trade cooperation.

Covering a total area of over 320,000 square meters, it will bring together nearly 5,000 brands and companies from more than 20 countries and regions and is expected to attract over 200,000 professional visitors and buyers from 150 countries and regions.

This year's CMEF highlights the rapid rise of AI, with a new lineup of "AI + healthcare" products reshaping the industry. Making its global debut, an AI agent capable of "one scan, multiple diagnoses" enables simultaneous detection of conditions across different parts of the body. A specialized AI diagnostic software suite is already in clinical use, while an integrated AI training and inference platform will enhance computing capabilities for healthcare institutions.

With advances in medical robotics, the exhibition will showcase new products across surgery, rehabilitation, and elderly care, driving the field toward greater intelligence and precision.

For the first time, CMEF is setting up a Future Tech Arena focusing on three key tracks: BCI, embodied intelligence, and university innovation achievements. The exhibition zone will showcase cutting-edge products such as AI-assisted MRI diagnostic systems for Alzheimer's disease, brain-computer interface systems for cognitive impairment assessment and training, and exoskeleton robots.

CMEF also serves as a premier trade hub for enterprise globalization and industry collaboration. The International Zone will host exhibitors from over 20 countries and regions, showcasing the latest global innovations, including Germany, the U.S., South Korea, Japan, the U.K., France, Singapore, Malaysia, and Thailand.

CMEF's upgraded "We" series of international brand activities will host the "WeTalk Stage," featuring representatives from foreign consulates, leading industry associations, and multinational corporations; the "WeMatch Hub" is designed to enable targeted matchmaking based on verified buyer demand; and the "International WeTour" customizes tours to help international visitors explore exhibitor offerings. During the show, CMEF will also partner with the international departments of several leading hospitals to provide tailored medical services, ensuring comprehensive healthcare support for global attendees.

Hundreds of forums will be held during the fair, bringing together global experts and industry leaders to explore the evolving healthcare landscape.

Global Harmonization Working Party (GHWP) and the Ministry of Health of Malaysia will convene to co-host a series of high‑level events, including the 3rd GHWP Innovative Medical Device Seminar and the ASEAN Forum on Medical Device Innovation and Collaboration (Shanghai). On‑site sessions will deliver targeted insights into regulatory policies and market access opportunities across key global markets, supporting the convergence and alignment of international medical device regulatory frameworks and facilitating more efficient global trade.

For registration, visit: https://reg.reed-sinopharm.com/pc/#/login?id=0fe1fc984f9147b49ad107cda4d97a88&channelUuid=744003af4a2b4310a819f2d14ff447f1

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

The 93rd CMEF is set to open in Shanghai, as the world's largest medical device industry exhibition spotlights AI, robotics, and international cooperation